Program

84
10
4
1

Journal Year Published

2
10
9
18
6
12
7
11
5
3
3

Author

86
182
174
134
134
125
118
116
114
108
88
81
73
56
51
50
43
43
42
34

Category

59
19
19
15
7
2
1
1

Keyword

37
23
16
15
14
12
12
10
7
7
6
6
6
6
5
5
5
5
5
5

Journal

8
5
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
1

NCATS Publications

A large scale high throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alpha.


Sengupta N, Jović M, Barnaeva E, Kim D, Hu X, Southall N, Dejmek M, Mejdrova I, Nencka R, Baumlova A, Chalupska D, Boura E, Ferrer-Alegre M, Marugan J, Balla T


J. Lipid Res. , 2019.

Article Pubmed

Sample image from publication page

DPTIP, a newly identified potent brain penetrant neutral sphingomyelinase 2 inhibitor, regulates astrocyte-peripheral immune communication following brain inflammation.


Rojas C, Barnaeva E, Thomas AG, Hu X, Southall N, Marugan J, Chaudhuri AD, Yoo SW, Hin N, Stepanek O, Wu Y, Zimmermann SC, Gadiano AG, Tsukamoto T, Rais R, Haughey N, Ferrer-Alegre M, Slusher BS


Sci Rep , (8), 17715, 2018.

Article Pubmed

Sample image from publication page

Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-KrasG12D/+;Tp53R172H/+ (KPC) mice, a genetically engineered model of pancreatic cancer.


Vilimas T, Wang A, Patnaik S, Hughes EA, Singleton MD, Knotts Z, Li D, Frankowski K, Schlomer JJ, Guerin TM, Springer S, Drennan C, Dextras C, Wang C, Gilbert D, Southall N, Ferrer-Alegre M, Huang S, Kozlov S, Marugan J, Xu X, Rudloff U


Cancer Chemother. Pharmacol. , 2018.

Article Pubmed

Sample image from publication page

Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease.


Vu M, Li R, Baskfield A, Lu B, Farkhondeh Kalat A, Gorshkov K, Motabar O, Beers J, Chen G, Zou J, Espejo-Mojica AJ, Rodríguez-López A, Alméciga-Díaz CJ, Barrera LA, Jiang X, Ory DS, Marugan J, Zheng W


Orphanet J Rare Dis , (13), 152, 2018.

Article Pubmed

Sample image from publication page